{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:38:22Z","timestamp":1792165102705,"version":"4.4.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.dsx.2020.03.009","type":"journal-article","created":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T02:08:45Z","timestamp":1585620525000},"page":"289-292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Dulaglutide reduces binge episodes in type 2 diabetic patients with binge eating disorder: A pilot study"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9995-0169","authenticated-orcid":false,"given":"Andrea","family":"Da Porto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Casarsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Colussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Catena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Cavarape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Sechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2020.03.009_bib1","series-title":"Diagnostic and statistical manual of mental disorders","year":"2013"},{"issue":"9","key":"10.1016\/j.dsx.2020.03.009_bib2","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.biopsych.2012.11.020","article-title":"The prevalence and correlates of binge eating disorder in World Health Organization world mental health survey","volume":"73","author":"Kessler","year":"2013","journal-title":"Biol Psychiatr"},{"key":"10.1016\/j.dsx.2020.03.009_bib3","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s11892-017-0949-1","article-title":"Are Eating Disorder risk factor for type 2 diabetes? A systematic review and meta-analysis","volume":"17","author":"Nieto-Martinez","year":"2017","journal-title":"Curr Diab Per"},{"issue":"12","key":"10.1016\/j.dsx.2020.03.009_bib4","article-title":"Prevalence and associations of binge eating disorder in a multiethnic population with type 2","volume":"29","author":"Meneghini","year":"2006","journal-title":"Diabetes Diabetes Care"},{"issue":"6","key":"10.1016\/j.dsx.2020.03.009_bib5","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1053\/j.gastro.2007.03.054","article-title":"Biology of incretins: GLP1 and GIP","volume":"132","author":"Baggio","year":"2007","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.dsx.2020.03.009_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1113\/jphysiol.2008.164012","article-title":"Nutritional regulation of glucacon like peptide 1 secretion","volume":"587","author":"Tolhurst","year":"2009","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.dsx.2020.03.009_bib7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11154-014-9289-5","article-title":"Effects of GLP1 on appetite and weigh","volume":"15","author":"Shah","year":"2014","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.dsx.2020.03.009_bib8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11154-014-9289-5","article-title":"Effects of GLP1 on appetite and weigh","volume":"15","author":"Shah","year":"2014","journal-title":"Rev Endocr Metab Disord"},{"issue":"supp 5","key":"10.1016\/j.dsx.2020.03.009_bib9","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1038\/sj.ijo.0801912","article-title":"Glucagon like Peptide containing pathways in the regulation of feeding behaviour","volume":"25","author":"Tang-Christensen","year":"2001","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.dsx.2020.03.009_bib10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000264401","article-title":"Hypothalamic brainstream circuits controlling eating","volume":"63","author":"Blevins","year":"2010","journal-title":"Forum Nutr"},{"issue":"4","key":"10.1016\/j.dsx.2020.03.009_bib11","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.2337\/db13-1440","article-title":"Identification and characterization of glucagon like peptide 1 receptor expressing cells using a new transgenic mouse model","volume":"63","author":"Richards","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2020.03.009_bib12","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.2337\/db14-0849","article-title":"GLP1 Receptor activation modulates appetite and rewarded related brain areas in humans","volume":"63","author":"van Bloemendaal","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2020.03.009_bib13","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s00125-016-3874-y","volume":"59","author":"Farr","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.dsx.2020.03.009_bib14","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.neubiorev.2016.01.013","volume":"63","author":"Kessler","year":"2016","journal-title":"Neurosci Biobehav Rev"},{"issue":"10","key":"10.1016\/j.dsx.2020.03.009_bib15","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1172\/JCI74726","article-title":"Estrogens stimulate serotonin neurons to inhibit binge like eating in mice","volume":"124","author":"Cao","year":"2014","journal-title":"J\u00a0Clin Invest"},{"issue":"171","key":"10.1016\/j.dsx.2020.03.009_bib16","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.physbeh.2016.12.034","article-title":"Systemic administration of anorexic gut peptide hormones impairs edonic driven sucrose consuption in mice","volume":"15","author":"Yamaguchi","year":"2017","journal-title":"Physiol Behav"},{"issue":"2","key":"10.1016\/j.dsx.2020.03.009_bib17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/eat.22264","article-title":"Preliminary examination of glucagon like peptide levels in woman with purging disorder and bulimia nervosa","volume":"48","author":"Dossat","year":"2015","journal-title":"Int J Eat Disord"},{"issue":"4","key":"10.1016\/j.dsx.2020.03.009_bib18","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3945\/ajcn.111.014837","article-title":"Women with bulimia nervosa exihibit attenuated secretion of glucagon like peptide, pancreatic polypeptide, and insulin in respose to a meal","volume":"94","author":"Naessen","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.dsx.2020.03.009_bib19","unstructured":"Geliebter A, Hashim SA, Gluck ME: Appetite related gut peptides, ghrelin, PYY and GLP1 in obese woman with and without binge eating disorder."},{"issue":"3","key":"10.1016\/j.dsx.2020.03.009_bib20","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2337\/ds16-0026","article-title":"Glucagon-Like peptide 1 receptor agonists for type 2 diabetes","volume":"30","author":"Hinnen","year":"2017","journal-title":"Diabetes Spectr"},{"issue":"3","key":"10.1016\/j.dsx.2020.03.009_bib21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.orcp.2015.03.005","article-title":"Wan Improvement in binge eating in non-diabetic obese individuals after 3 months of treatment with liraglutide - a pilot study","volume":"9","author":"Robert","year":"2015","journal-title":"Obes Res Clin Pract"},{"issue":"10","key":"10.1016\/j.dsx.2020.03.009_bib22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3389\/fpsyt.2019.00097","article-title":"Beneficial effects of GLP-1 agonist in a male with compulsive food-related behavior associated with autism","volume":"2019","author":"J\u00e4rvinen","year":"2019","journal-title":"Front Psychiatr"},{"issue":"37","key":"10.1016\/j.dsx.2020.03.009_bib23","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.2337\/dc13-2761","article-title":"Efficacy and safety of dulaglutide versus sitagliptin after 52 weeks in type 2 diabetes in a randomized controlled trial (AWARD-5)","volume":"2014","author":"Nauck","year":"2014","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.dsx.2020.03.009_bib24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13098-018-0331-8","article-title":"Effectiveness of gliclazide MR 60 mg in the management of type 2 diabetes: analyses from the EASYDia trial","volume":"2018","author":"Leiter","year":"2018","journal-title":"Diabetol Metab Syndrome"},{"key":"10.1016\/j.dsx.2020.03.009_bib25","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.diabres.2015.11.001","article-title":"Implementing an optimized glucose-lowering strategy with a novel once daily modified release gliclazide formulation","volume":"112","author":"Leiter","year":"2016","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"10.1016\/j.dsx.2020.03.009_bib26","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.diabres.2010.05.012","article-title":"The efficacy of lowering glycated haemoglobin with a gliclazide modified release-based intensive glucose lowering regimen in the ADVANCE trial","volume":"89","author":"Zoungas","year":"2010","journal-title":"Diabetes Res Clin Pract"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402120300497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402120300497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:14:00Z","timestamp":1761729240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402120300497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1871402120300497"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2020.03.009","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dulaglutide reduces binge episodes in type 2 diabetic patients with binge eating disorder: A pilot study","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2020.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}